Financials data is unavailable for this security.
View more
Year on year GSK plc had net income fall -67.05% from 14.96bn to 4.93bn despite a 3.42% increase in revenues from 29.32bn to 30.33bn. An increase in the selling, general and administrative costs as a percentage of sales from 27.72% to 29.77% was a component in the falling net income despite rising revenues.
| Gross margin | 72.44% |
|---|---|
| Net profit margin | 9.10% |
| Operating margin | 12.45% |
| Return on assets | 4.79% |
|---|---|
| Return on equity | 18.50% |
| Return on investment | 7.48% |
More ▼
Cash flow in GBPView more
In 2023, cash reserves at GSK plc fell by 567.00m. However, the company earned 6.77bn from its operations for a Cash Flow Margin of 22.32%. In addition the company used 1.60bn on investing activities and also paid 5.64bn in financing cash flows.
| Cash flow per share | 1.36 |
|---|---|
| Price/Cash flow per share | 9.61 |
| Book value per share | 3.43 |
|---|---|
| Tangible book value per share | -1.88 |
More ▼
Balance sheet in GBPView more
| Current ratio | 0.8061 |
|---|---|
| Quick ratio | 0.5303 |
| Total debt/total equity | 1.15 |
|---|---|
| Total debt/total capital | 0.5442 |
More ▼
Growth rates in GBP
Year on year, growth in dividends per share fell -5.31% while earnings per share excluding extraordinary items rose 15.03%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 5.47% |
|---|---|
| Div growth rate (5 year) | -10.32% |
| Payout ratio (TTM) | 98.96% |
| EPS growth(5 years) | 6.39 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -58.96 |
More ▼
